Company news

Celyad Oncology SA news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Celyad Oncology Reports First Half Year 2026 Results

September 23, 2026

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

July 22, 2026

Celyad Oncology Announces €500,000 Private Placement

July 14, 2026

Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights

April 2, 2026

Celyad Oncology Announces the Sale of C-CATHez ® Catheter

February 12, 2026

Celyad Oncology: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

November 25, 2025

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

November 14, 2025

Celyad Oncology Announces Research Facility Divestiture

September 29, 2025

Celyad Oncology Reports First Half Year 2025 Financial Results

September 25, 2025

Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

September 11, 2025

Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

September 4, 2025

Celyad Oncology Announces Discontinuation of R&D Activities

August 26, 2025

Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC

August 13, 2025

Celyad Oncology Announces €1 Million Private Placement

July 28, 2025

Celyad Oncology Announces Strategic Review

June 24, 2025

Report of the Statutory Auditor on the Consolidated Annual Account 2024 ENG

April 18, 2025

Annual Report 2024 ENG

April 18, 2025

Information Note to Shareholders ENG

April 18, 2025

Celyad Oncology Reports Full Year 2024 Financial Results and Recent Business Highlights

April 2, 2025

Celyad Oncology announces the publication of the preclinical and clinical data of CYAD 211 providing proof of concept of its miRNA based shRNA platform

February 18, 2025

Celyad Oncology reports full year 2023 financial results and recent business highlights

April 5, 2024

Report of the Statutory Auditor on the Consolidated Annual Account 2023 ENG

April 5, 2024

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

January 16, 2024

Celyad Oncology announces management change

December 1, 2023

Celyad Oncology reports third quarter 2023 financial results and recent business highlights - Form 6-K

November 24, 2023

Decks

The 5 newest of 13 decks. Every deck is listed under its year.